Johnny Huard, PhD
Professor of Orthopaedic Surgery, Molecular Genetics and Biochemistry, Bioengineering, and Pathology
Henry J. Mankin, MD Endowed Chair in Orthopaedic Surgery
Dr. Huard is Director of the Stem Cell Reearch Center, a member of the McGowan Institute of Regenerative Medicine, and a member of the Cellular and Molecular Pathology Graduate Training Program.
Bridgeside Point II Bldg, Suite 206
450 Technology Drive
Pittsburgh, PA 15219
Office Telephone: 412-648-2798
Research InterestsDr. Huard’s main research focus is to expand the possibilities of tissue engineering by unlocking the potential of gene therapy and adult stem cell research and transferring research findings into the development of effective treatments for damaged or diseased tissues as they relate to the musculoskeletal system. He has established international recognition for his research discoveries in this area and made significant preclinical advances in the isolation, identification and characterization of muscle-derived stem cells. He is currently using those findings to explore and develop cutting-edge treatment programs to address Duchenne muscular dystrophy (DMD) and a variety of orthopaedic diseases and injuries including muscle injuries and repair and regeneration of bone and articular cartilage. Dr. Huard’s research program is funded by a variety of sources including the National Institutes of Health, the Muscular Dystrophy Association, as well as other private and public foundations.
Awards and Honors
- Chancellor’s Distinguished Research Award, University of Pittsburgh
- Prix D’Excellence, University of Quebec
Selected PublicationsView Dr. Huard's publications on PubMed
Cooper GM, Mooney MP, Gosain AK, Campbell PG, Losee JE, Huard J. Testing the critical size in calvarial bone defects: revisiting the concept of a critical-size defect. Plastic and Reconstructive Surgery. 2010 Jun;125(6):1685-92. PMCID: 2946111.
Clause KC, Tinney JP, Liu LJ, Gharaibeh B, Huard J, Kirk JA, Shroff SG, Fujimoto KL, Wagner WR, Ralphe JC, Keller BB, Tobita K. A three-dimensional gel bioreactor for assessment of cardiomyocyte induction in skeletal muscle-derived stem cells. Tissue Engineering Part C. Methods. 2010 Jun;16(3):375-85. PMCID: 2945363.
Cooper GM, Miller ED, Decesare GE, Usas A, Lensie EL, Bykowski MR, Huard J, Weiss LE, Losee JE, Campbell PG. Inkjet-based biopatterning of bone morphogenetic protein-2 to spatially control calvarial bone formation. Tissue Engineering Part A. 2010 May;16(5):1749-59. PMCID: 2952127.
Nieponice A, Soletti L, Guan J, Hong Y, Gharaibeh B, Maul TM, Huard J, Wagner WR, Vorp DA. In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model. Tissue Engineering Part A. 2010 Apr;16(4):1215-23. PMCID: 2862609.
Tang Y, Cummins J, Huard J, Wang B. AAV-directed muscular dystrophy gene therapy. Expert Opinion on Biological Therapy. 2010 Mar;10(3):395-408. Review. PMID: 20132060.